CAS 56990-57-9

(7E)-8-oxo-7-[(6-sulfonaphthalen-2-yl)hydrazono]-7,8-dihydroquinoline-5-sulfonic acid

Description:

The chemical substance known as (7E)-8-oxo-7-[(6-sulfonaphthalen-2-yl)hydrazono]-7,8-dihydroquinoline-5-sulfonic acid, with the CAS number 56990-57-9, is a complex organic compound characterized by its unique structural features. It contains a quinoline core, which is a bicyclic structure known for its aromatic properties and biological activity. The presence of a hydrazone functional group indicates potential reactivity and the ability to form coordination complexes. Additionally, the sulfonic acid groups contribute to its solubility in water and enhance its ionic character, making it useful in various applications, including pharmaceuticals and dyes. The compound's sulfonaphthalenyl substituent suggests potential interactions with biological targets, which may lead to interesting pharmacological properties. Overall, this compound's intricate structure and functional groups position it as a candidate for further research in medicinal chemistry and material science.

Formula: C₁₉H₁₃N₃O₇S₂

InChI: InChI=1/C19H13N3O7S2/c23-19-16(10-17(31(27,28)29)15-2-1-7-20-18(15)19)22-21-13-5-3-12-9-14(30(24,25)26)6-4-11(12)8-13/h1-10,21H,(H,24,25,26)(H,27,28,29)/b22-16+

NSC-87877

CAS: 56990-57-9

NSC-87877 inhibits Shp2 (IC50=0.318μM), Shp1 (IC50=0.355μM), and DUSP26 phosphatases.

Formula: C₁₉H₁₃N₃O₇S₂

Purity: 97.35%

Color and Shape: Solid

Molecular weight: 459.45

Ref: TM-T16350

5-Quinolinesulfonic acid, 8-hydroxy-7-(6-sulfo-2-naphthylazo)-

CAS: 56990-57-9

Formula: C₁₉H₁₃N₃O₇S₂

Purity: 98%

Molecular weight: 459.4524

Ref: IN-DA00EEGK

NSC-87877

CAS: 56990-57-9

NSC-87877

Purity: ≥95%

Molecular weight: 459.45g/mol

Ref: 54-BUP05989

NSC 87877

Controlled Product

CAS: 56990-57-9

Formula: C₁₉H₁₃N₃O₇S₂

Color and Shape: Neat

Molecular weight: 459.452

Ref: TR-N900350

NSC 87877

CAS: 56990-57-9

NSC 87877 is a chemical inhibitor that inhibits the activity of protein kinase C (PKC). It has been shown to inhibit the tyrosine phosphatase, leading to neuronal death. NSC 87877 also has angiogenic properties and can be used for the treatment of some cancers. The PKC inhibitors have been shown to decrease cellular proliferation and induce cell cycle arrest by interfering with signal pathways. This drug may be able to interfere with PKC-mediated signal cascades that regulate cell growth and differentiation, thereby providing a possible therapeutic target for cancer therapy.

Formula: C₁₉H₁₃N₃O₇S₂

Purity: Min. 95%

Molecular weight: 459.45 g/mol

Ref: 3D-GCA99057